Given its role in promoting cancer cell survival, ATF6 represents a potential therapeutic target. Inhibiting ATF6 function could increase ER stress levels in tumor cells, leading to apoptosis and reduced tumor growth. Several strategies, including small molecules and RNA interference (RNAi) approaches, are being explored to target ATF6 in cancer therapy.
